地塞米松植入劑多次異位于前房1例_Chinese Journal of Ocular Fundus Diseases

Authors：

馬為梅 , 王睿 , 車欣 , 張妍春 , 屈超義 ,  周云云

西安市人民醫院（西安市第四醫院）眼科, 西安 710004;

Corresponding?author：

周云云, Email: 1582880694@qq.com

Keywords：

地塞米松眼內植入劑; 異位; 前房; 病例報告

DOI：

10.3760/cma.j.cn511434-20250428-00191

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： 馬為梅, 王睿, 車欣, 張妍春, 屈超義, 周云云. 地塞米松植入劑多次異位于前房1例. Chinese Journal of Ocular Fundus Diseases, 2026, 42(3): 246-248. doi: 10.3760/cma.j.cn511434-20250428-00191 Copy

1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.	Tsoutsanis P, Kapantais D. Anterior migration of Ozurdex implant: a review on risk factors, complications, and management[J/OL]. Int J Retina Vitreous, 2023, 9(1): 74[2023-11-27]. https://pubmed.ncbi.nlm.nih.gov/38012689/. DOI: 10.1186/s40942-023-00513-5.
13.	R?ck D, Bartz-Schmidt KU, R?ck T. Risk factors for and management of anterior chamber intravitreal dexamethasone implant migration[J/OL]. BMC Ophthalmol, 2019, 19(1): 120[2019-05-28]. https://pubmed.ncbi.nlm.nih.gov/31138164/. DOI: 10.1186/s12886-019-1122-1.
14.

1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12. Tsoutsanis P, Kapantais D. Anterior migration of Ozurdex implant: a review on risk factors, complications, and management[J/OL]. Int J Retina Vitreous, 2023, 9(1): 74[2023-11-27]. https://pubmed.ncbi.nlm.nih.gov/38012689/. DOI: 10.1186/s40942-023-00513-5.
13. R?ck D, Bartz-Schmidt KU, R?ck T. Risk factors for and management of anterior chamber intravitreal dexamethasone implant migration[J/OL]. BMC Ophthalmol, 2019, 19(1): 120[2019-05-28]. https://pubmed.ncbi.nlm.nih.gov/31138164/. DOI: 10.1186/s12886-019-1122-1.
14.

Previous Article
程序性死亡蛋白-1抑制劑相關葡萄膜炎3例
Next Article
Vogt-Koyanagi-Harada綜合征繼發雙眼閉角性青光眼1例

Chinese Journal of Ocular Fundus Diseases

地塞米松植入劑多次異位于前房1例

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content